About
CME Information
Faculty
Program
Register
Next Gen Banner

Next Generation Migraine Therapies – Chicago

May162020

The Next Generation Migraine Therapies (NGMT) initiative is a comprehensive program designed to provide a multi-faceted approach to migraine education offered at no cost to healthcare providers including neurologists, primary care physicians and advanced practice providers. Brought to you by the American Headache Society, the program covers topics around the diagnosis and treatment of migraine, and updates on the latest science around the disease. Through a mix of regional in-person workshops, NGMT is designed to engage participants through didactic and interactive case study workshops. Register at no cost to attend our Chicago event here.

  • Diagnosis and treatment
    • Acute and Preventative treatment options
    • What works well and what are the unmet needs?
    • Risks for migraine progression
  • The latest science
    • State of the art therapeutic options
    • Multi format administration options
    • CGRP receptors as a target for small molecules: GPANTs
    • Immunology, antibodies, and monoclonal antibodies
    • Neuromodulation update
  • Answer questions such as
    • How can peripherally acting drugs treat migraine?
    • What do I need to know about monoclonal antibodies that treat migraine?
    • How do I best identify appropriate patients for the appropriate therapeutic option?
    • What do I need to know to identify appropriate patients for these emerging therapies?

Register Now

Next Gen Banner

Next Generation Migraine Therapies – Chicago

May162020

Who Should Attend
This program is designed for Neurologists, Family Practitioners, Internists, and other health professionals who would like more information on the proper diagnosis and treatment of chronic migraine patients.

Learning Objectives

  • Recognize the distribution of migraine and unmet needs on current treatments
  • Discuss insights from basic science that underlie the next generation of migraine therapeutics
  • Utilize calcitonin gene-related peptide (CGRP)-targeted therapies in migraine prevention
  • Individualize and optimize migraine treatment using current and emerging therapeutic options

CME Statement

AHS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians. AHS takes responsibility for the content, quality, and scientific integrity of this CME activity.

The American Headache Society® designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credit(s)™; 4.0 AMA PRA Category 1 Credit(s)™ for the morning program and 3.50 AMA PRA Category 1 Credit(s)™ for the afternoon program. Physicians should only claim credit commensurate with the extent of their participation in the activity.

AAFP

This Live activity, Next Generation Migraine Therapies, from 03/21/2020 – 05/16/2020, has been reviewed and is acceptable for up to 8.25 Prescribed credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Next Gen Banner

Next Generation Migraine Therapies – Chicago

May162020

Faculty


Kathleen Digre, MD, FAHS

University of Utah
Salt Lake City, UT

Deborah I. Friedman, MD, MPH, FAHS
UT Southwestern
Dallas, TX

Rashmi Halker Singh, MD, FAHS

Mayo Clinic
Phoenix, AZ

Scott Powers, PhD, FAHS

University of Cincinnati
College of Medicine
Cincinnati, OH
Next Gen Banner

Next Generation Migraine Therapies – Chicago

May162020

Download the program brochure including preliminary program agenda here.

Next Generation Migraine Therapies

May 16, 2020 | Sheraton Grand Chicago

Chicago, IL | Chicago 6-7

7:00 am – 7:45 am Course Registration and Continental Breakfast
7:45 am – 8:00 am Introduction, Program Overview and Pre-test

Kathleen B. Digre, MD, FAHS

8:00 am – 9:00 am                           State of the Art
8:00 am – 8:20 am Migraine Diagnosis

Migraine Epidemiology and Impact

Kathleen B. Digre, MD, FAHS

8:20 am – 8:45 am Pathophysiologic Foundations of New Therapeutics (applied pathophysiology)

Kathleen B. Digre, MD, FAHS

8:45 am – 9:00 am Q&A
9:00 am – 10:15 am Next Generation Acute Treatment: Addressing Unmet Needs
9:00 am – 9:30 am Unmet Needs, Current Treatment and Novel Approaches to Treatment Delivery

Deborah I. Friedman, MD, MPH, FAHS

9:30 am – 10:00 am Cardiovascular Safety: Ditans, Gepants and Neuromodulation

Deborah I. Friedman, MD, MPH, FAHS

10:00 am – 10:15 am Q&A
10:15 am – 10:30 am Break
10:30 am – 12:00 pm Next Generation Preventive Treatment
10:30 am – 10:50 am Current Treatment and Unmet Needs

Rashmi B. Halker Singh, MD, FAHS

10:50 am – 11:10 am Immunology, Antibodies and Monoclonal Antibodies

Rashmi B. Halker Singh, MD, FAHS

11:10 am – 11:30 am Anti-CGRP Antibodies and Other Migraine Biologics

Rashmi B. Halker Singh, MD, FAHS

11:30 am – 11:45 am Behavioral Interventions

Scott W. Powers, PhD, ABPP, FAHS

11:45 am – 12:00 pm Q&A
12:00 pm – 1:15 pm Working Lunch: Case Discussions

All Faculty

1:15 pm – 1:30 pm Break
1:30 pm – 4:45 pm Procedures, Devices and Non-pharmacological Treatment Workshops

Attendees will be broken into two (2) groups. Each group will be assigned a workshop initially and then switch to the other at the break allowing attendees to attend both workshops. Workshop assignment is noted on the back of the attendee name badge.

1:30 pm – 3:00 pm Workshop 1: Procedures: Nerve Blocks and OnabotulinumtoxinA
1:30 pm – 2:15 pm Nerve Blocks and OnabotulinumtoxinA with Q&A

Rashmi B. Halker Singh, MD, FAHS

2:15 pm – 3:00 pm Headache Procedures Hands-on Training

Rashmi B. Halker Singh, MD, FAHS

 

Hands-on Demonstrators:

Rashmi B. Halker Singh, MD, FAHS

Others TBD

1:30 pm – 3:00 pm Workshop 2: Nonpharmacologic Treatments
1:30 pm – 2:15 pm Current Devices and Procedures with Q&A

Deborah I. Friedman, MD, MPH, FAHS

2:15 pm – 3:00 pm Behavioral Enhancements to Migraine Management with Q&A

Scott W. Powers, PhD, ABPP, FAHS

3:00 pm – 3:15 pm Break (attendees switch rooms-workshops repeat)
3:15 pm – 4:45 pm Workshop 1: Procedures: Nerve Blocks and OnabotulinumtoxinA
3:15 pm – 4:00 pm Nerve Blocks and OnabotulinumtoxinA with Q&A

Rashmi B. Halker Singh, MD, FAHS

4:00 pm – 4:45 pm Headache Procedures Hands-on Training

Rashmi B. Halker Singh, MD, FAHS

 

Hands-on Demonstrators:

Rashmi B. Halker Singh, MD, FAHS

Others TBD

3:15 pm – 4:45 pm Workshop 2: Nonpharmacologic Treatments
3:15 pm – 4:00 pm Current Devices and Procedures with Q&A

Deborah I. Friedman, MD, MPH, FAHS

4:00 pm – 4:45 pm Behavioral Enhancements to Migraine Management with Q&A

Scott W. Powers, PhD, ABPP, FAHS

 

Next Gen Banner

Next Generation Migraine Therapies – Chicago

May162020

Online registration is now open. To register at no cost, click here.

View the preliminary program brochure here.

Latest Tweets